ISCHEMIC HEART DISEASE AND METABOLIC SYNDROME IN ELDERLY PATIENTS

dc.contributor.authorI. G. Adilova
dc.contributor.authorG. M. Tulaboeva
dc.contributor.authorK. M. Sagatova
dc.contributor.authorYu. Sh. Talipova
dc.contributor.authorN. M. Abdukodirova
dc.date.accessioned2025-12-28T10:50:21Z
dc.date.issued2025-09-15
dc.description.abstractRelevance. Ischemic heart disease (IHD) and metabolic syndrome (MS) are among the leading causes of death and disability worldwide. Both conditions are urgent due to the commonality of risk factors, the high likelihood of complications, and the need to strengthen prevention, diagnosis, and treatment measures in the healthcare field.
dc.formatapplication/pdf
dc.identifier.urihttps://usajournals.org/index.php/2/article/view/933
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/4326
dc.language.isoeng
dc.publisherModern American Journals
dc.relationhttps://usajournals.org/index.php/2/article/view/933/1006
dc.rightshttps://creativecommons.org/licenses/by/4.0
dc.sourceModern American Journal of Engineering, Technology, and Innovation; Vol. 1 No. 6 (2025); 24-29
dc.source3067-7939
dc.titleISCHEMIC HEART DISEASE AND METABOLIC SYNDROME IN ELDERLY PATIENTS
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
adilova_2025_ischemic_heart_disease_and_metabolic_syn.pdf
item.page.filesection.size
308.72 KB
item.page.filesection.format
Adobe Portable Document Format